Sandbox:Zahir: Difference between revisions

Jump to navigation Jump to search
Line 263: Line 263:
| style="background: #F5F5F5; padding: 5px;" |iron deficiency anemia
| style="background: #F5F5F5; padding: 5px;" |iron deficiency anemia
| style="background: #F5F5F5; padding: 5px;" |N/A
| style="background: #F5F5F5; padding: 5px;" |N/A
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |blood on stool outer surface
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |done if colorectal cancer suspected
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |N/A
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |N/A
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |N/A
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |DRE + anoscopy
| style="background: #F5F5F5; padding: 5px;" |anoscopy shows bulging purplish hue veins or dark, pink, glistening mass
| style="background: #F5F5F5; padding: 5px;" |anoscopy shows bulging purplish hue veins or dark, pink, glistening mass
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |None
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Rectal intususception
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Rectal intususception

Revision as of 16:38, 24 January 2019


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Zahir Ali Shaikh, MD[2]

Differentiating [Disease name] from other Diseases

[Disease name] must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as [differential dx1], [differential dx2], and [differential dx3].

OR

[Disease name] must be differentiated from [differential dx1], [differential dx2], and [differential dx3].

OR

As [disease name] manifests in a variety of clinical forms, differentiation must be established in accordance with the particular subtype. [Subtype name 1] must be differentiated from other diseases that cause [clinical feature 1], such as [differential dx1] and [differential dx2]. In contrast, [subtype name 2] must be differentiated from other diseases that cause [clinical feature 2], such as [differential dx3] and [differential dx4].

Differentiating [disease name] from other diseases on the basis of [symptom 1], [symptom 2], and [symptom 3]

On the basis [symptom 1], [symptom 2], and [symptom 3], [disease name] must be differentiated from [disease 1], [disease 2], [disease 3], [disease 4], [disease 5], and [disease 6].

Diseases Clinical manifestations Diagnosis Gold standard Additional findings Others
Symptoms Physical examination
Lab Findings Imaging
Abdominal pain Bowel habits Blood in stool Weight loss General appearance Abdominal exam Rectal exam Genitourinary exam CBC Tumor markers Stool test Colonoscopy Barium enema Ultrasound CT scan
Rectal carcinoma[1][2][3][4][5] LLQ Constipation/diarrhea + +
  • lethargy
  • pallor
  • confusion
  • emaciation
  • tendernes
  • hepatomegaly
  • ascites
  • absent bowel sounds
  • rectal mass
  • rectal bleeding
NL Anmeia
  • ↑ CEA
  • ↑ CA19-9
FOBT+ mass/polyp Apple core apearance endoscopic/trnasrectal US detects tumor extent determine tumor stage colonoscopy with biopsy DRE & proctoscopy detects tumor localization & extension
  • ↓ serum iron
  • ↓ vit: B12 & folate
Rectal polyp[6][7][8] + mucous diarrhea + + NL NL rectal mass/polyp NL NL/anemia NL FOBT+ Polyp N/A Polyp N/A colonoscopy with biopsy
  • hypoproteinemia
  • hypoalbuminemia
N/A
Anal cancer[9][10][11][12] +/- constipation/diarrhea + +/- NL NL lump/mass at anal opening NL NL/anemia N/A FOBT+ N/A N/A determines anal cancer depth into sphincter hypoattenuated necrotic mass on contrast CT Biopsy PET/CT detects localization of small anal tumors <2cm sentinal lymph node biopsy detects lymph node metastases
Hemorrhoids +/- fecal incontinence/mucous discharge + - NL/weakness,irritability NL
  • palpable perianal lump
  • bleeding PR
NL iron deficiency anemia N/A blood on stool outer surface done if colorectal cancer suspected N/A N/A N/A DRE + anoscopy anoscopy shows bulging purplish hue veins or dark, pink, glistening mass None
Rectal intususception
Foreign body[13][14][15][16] Anorectal pain and abdominal pain Constipation + -
  • Palpable foreign body
  • Generalized abdominal pain
  • Absent bowel sounds
  • Rigidity
  • Signs of peritonitis
NL
  • Leucocytosis
  • Metabolic acidosis
NL FOBT+ Foreign body Contraindicated Foreign body Foreign body Plain radiographs show presence of foreign body NL NL
Diseases Abdominal pain Bowel habits Blood in stool Weight loss General appearance Abdominal exam Rectal exam Genitourinary exam CBC Tumor markers Stool test Colonoscopy Barium enema Ultrasound CT scan Others Gold standard Additional findings
Prostate cancer
Fecal impaction
Anal stenosis
Hypertrophied anal papillae
Endometriosis
Uterine malignancy
Diseases Abdominal pain Bowel habits Blood in stool Weight loss General appearance Abdominal exam Rectal exam Genitourinary exam CBC Tumor markers Stool test Colonoscopy Barium enema Ultrasound CT scan Others Gold standard Additional findings
Cervical malignancy
Metastases
Pelvic abscess
Pelvic sarcoma
Parasacral neurogenic tumor

References

  1. Chiara Molinari, Federica Matteucci, Paola Caroli & Alessandro Passardi (2015). "Biomarkers and Molecular Imaging as Predictors of Response to Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer". Clinical colorectal cancer. 14 (4): 227–238. doi:10.1016/j.clcc.2015.05.014. PMID 26170142. Unknown parameter |month= ignored (help)
  2. William Hamilton & Deborah Sharp (2004). "Diagnosis of colorectal cancer in primary care: the evidence base for guidelines". Family practice. 21 (1): 99–106. PMID 14760054. Unknown parameter |month= ignored (help)
  3. Wolfgang B. Gaertner, Mary R. Kwaan, Robert D. Madoff & Genevieve B. Melton (2015). "Rectal cancer: An evidence-based update for primary care providers". World journal of gastroenterology. 21 (25): 7659–7671. doi:10.3748/wjg.v21.i25.7659. PMID 26167068. Unknown parameter |month= ignored (help)
  4. V. Raman Muthusamy & Kenneth J. Chang (2007). "Optimal methods for staging rectal cancer". Clinical cancer research : an official journal of the American Association for Cancer Research. 13 (22 Pt 2): 6877s–6884s. doi:10.1158/1078-0432.CCR-07-1137. PMID 18006793. Unknown parameter |month= ignored (help)
  5. Mohammad Sadegh Fazeli & Mohammad Reza Keramati (2015). "Rectal cancer: a review". Medical journal of the Islamic Republic of Iran. 29: 171. PMID 26034724.
  6. N. Oshitani, Y. Moriyama, T. Matsumoto, K. Kobayashi & A. Kitano (1995). "Protein-losing enteropathy from cap polyposis". Lancet (London, England). 346 (8989): 1567. PMID 7491082. Unknown parameter |month= ignored (help)
  7. Ioannis Papaconstantinou, Andreas Karakatsanis, Xanthi Benia, George Polymeneas & Evanthia Kostopoulou (2012). "Solitary rectal cap polyp: Case report and review of the literature". World journal of gastrointestinal surgery. 4 (6): 157–162. doi:10.4240/wjgs.v4.i6.157. PMID 22816031. Unknown parameter |month= ignored (help)
  8. Kheng-Hong Ng, Pawan Mathur, M. Priyanthi Kumarasinghe, Kong-Weng Eu & Francis Seow-Choen (2004). "Cap polyposis: further experience and review". Diseases of the colon and rectum. 47 (7): 1208–1215. doi:10.1007/s10350-004-0561-8. PMID 15164251. Unknown parameter |month= ignored (help)
  9. Thomas G. Trautmann & James H. Zuger (2005). "Positron Emission Tomography for pretreatment staging and posttreatment evaluation in cancer of the anal canal". Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging. 7 (4): 309–313. doi:10.1007/s11307-005-0003-6. PMID 16028002. Unknown parameter |month= ignored (help)
  10. D. R. Radin (1994). "Squamous cell carcinoma of the anus and rectum in homosexual men: CT findings". Journal of computer assisted tomography. 18 (6): 921–924. PMID 7962800. Unknown parameter |month= ignored (help)
  11. S. D. Otto, L. Lee, H. J. Buhr, B. Frericks, S. Hocht & A. J. Kroesen (2009). "Staging anal cancer: prospective comparison of transanal endoscopic ultrasound and magnetic resonance imaging". Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 13 (7): 1292–1298. doi:10.1007/s11605-009-0870-2. PMID 19365694. Unknown parameter |month= ignored (help)
  12. Sajad Ahmad Salati & Azzam Al Kadi (2012). "Anal cancer - a review". International journal of health sciences. 6 (2): 206–230. PMID 23580899. Unknown parameter |month= ignored (help)
  13. Ooi BS, Ho YH, Eu KW, Nyam D, Leong A, Seow-Choen F (December 1998). "Management of anorectal foreign bodies: a cause of obscure anal pain". Aust N Z J Surg. 68 (12): 852–5. PMID 9885867.
  14. Lake JP, Essani R, Petrone P, Kaiser AM, Asensio J, Beart RW (October 2004). "Management of retained colorectal foreign bodies: predictors of operative intervention". Dis. Colon Rectum. 47 (10): 1694–8. PMID 15540301.
  15. Stack LB, Munter DW (August 1996). "Foreign bodies in the gastrointestinal tract". Emerg. Med. Clin. North Am. 14 (3): 493–521. PMID 8681881.
  16. Goldberg JE, Steele SR (February 2010). "Rectal foreign bodies". Surg. Clin. North Am. 90 (1): 173–84, Table of Contents. doi:10.1016/j.suc.2009.10.004. PMID 20109641.